This isn't a name I'd play aggressively into earnings, but a small gamble here could pay off in a big way.
The charts tell me there's trouble here.
Let's review the charts again after its latest earnings report.
Overall I think QDEL can trade higher.
Let's review the charts and indicators.
Data and valuation metrics are becoming more encouraging.
The focus when it comes to MRNA is the timing of mRNA-1273, the firm's two dose hopeful protection against Covid.
Jim Cramer has identified a 5G wireless bull market.
Let's wait and see how this develops.
The shares have traveled a long way from the white-knuckle low of early April.